S Moss

Summary

Affiliation: Queen Mary
Country: UK

Publications

  1. doi request reprint Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial
    Sue M Moss
    Wolfson Institute, Queen Mary University of London, London, UK Electronic address
    Lancet Oncol 16:1123-32. 2015
  2. ncbi request reprint The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies
    S M Moss
    Centre for Cancer Prevention, Queen Mary University of London, Wolfson Institute for Preventive Medicine, London, UK
    J Med Screen 19:26-32. 2012
  3. ncbi request reprint European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Evaluation and interpretation of screening outcomes
    S Moss
    Centre for Cancer Prevention, Wolfson Institute, Queen Mary University of London, United Kingdom
    Endoscopy 44:SE49-64. 2012
  4. doi request reprint Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study
    S W Duffy
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, London, UK
    Health Technol Assess 17:vii-xiv, 1-95. 2013
  5. ncbi request reprint Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer
    J Mackay
    North East Thames Regional Genetics Service, Institute of Child Health, London, UK
    J Epidemiol Biostat 6:365-9; discussion 371-5. 2001
  6. doi request reprint Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
    Wendy S Atkin
    Department of Surgery and Cancer, Imperial College London, London, UK
    Lancet 375:1624-33. 2010

Detail Information

Publications6

  1. doi request reprint Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial
    Sue M Moss
    Wolfson Institute, Queen Mary University of London, London, UK Electronic address
    Lancet Oncol 16:1123-32. 2015
    ..Here, we report the results of the UK Age trial after 17 years of follow-up...
  2. ncbi request reprint The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies
    S M Moss
    Centre for Cancer Prevention, Queen Mary University of London, Wolfson Institute for Preventive Medicine, London, UK
    J Med Screen 19:26-32. 2012
    ..We reviewed such studies of population-based screening in Europe to assess their value...
  3. ncbi request reprint European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Evaluation and interpretation of screening outcomes
    S Moss
    Centre for Cancer Prevention, Wolfson Institute, Queen Mary University of London, United Kingdom
    Endoscopy 44:SE49-64. 2012
    ....
  4. doi request reprint Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study
    S W Duffy
    Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, London, UK
    Health Technol Assess 17:vii-xiv, 1-95. 2013
    ..Up to now, this strategy has not been fully evaluated...
  5. ncbi request reprint Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer
    J Mackay
    North East Thames Regional Genetics Service, Institute of Child Health, London, UK
    J Epidemiol Biostat 6:365-9; discussion 371-5. 2001
    ..Incremental cost-effectiveness ratios of implementing the standardised mammography strategy compared with no screening will be presented in terms of the additional cost per cancer detected, per life saved and per life-year saved...
  6. doi request reprint Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
    Wendy S Atkin
    Department of Surgery and Cancer, Imperial College London, London, UK
    Lancet 375:1624-33. 2010
    ..We tested the hypothesis that only one flexible sigmoidoscopy screening between 55 and 64 years of age can substantially reduce colorectal cancer incidence and mortality...